Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.

The MIT Festival of Learning sparked discussions on better integrating a sense of purpose and social responsibility into hands-on education.

MIT biologists have found that defects in some transfer RNA molecules can lead to the formation of these common conditions.

MIT associate professor recognized for exceptional distinction in teaching, research, and service at MIT.

CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.

Scientists have found that trees in cities respond to higher temperatures differently than those in forests, potentially masking climate impacts.

The American Association for the Advancement of Science recognizes six current affiliates and 27 additional MIT alumni for their efforts to advance science and related fields.

The research may enable the design of synthetic, light-activated cells for wound healing or drug delivery.

Stuart Levine ’97, director of MIT’s BioMicro Center, keeps departmental researchers at the forefront of systems biology.

A new analysis suggests our language capacity existed at least 135,000 years ago, with language used widely perhaps 35,000 years after that.

The Institute also ranks second in seven subject areas.

The findings provide new drug targets for stopping the infection’s spread.

At an MIT-led event at AJAS/AAAS, researchers connect with MIT faculty, Nobel laureates, and industry leaders to share their work, gain mentorship, and explore future careers in science.

Spheric Bio’s implants are designed to grow in a channel of the heart to better fit the patient’s anatomy and prevent strokes.

The programmable proteins are compact, modular, and can be directed to modify DNA in human cells.

Stefani Spranger is working to discover why some cancers don’t respond to immunotherapy, in hopes of making them more vulnerable to it.

Markey Freudenburg-Puricelli, Christina Kim ’24, Abigail Schipper ’24, and Rachel Zhang ’21 will pursue graduate studies at Cambridge University in the U.K.

FragFold, developed by MIT Biology researchers, is a computational method with potential for impact on biological research and therapeutic applications.

Colleagues remember the longtime MIT professor as a supportive, energetic collaborator who seemed to know everyone at the Institute.

They identified proteins that influence splicing of about half of all human introns, allowing for more complex types of gene regulation.

Whitehead Institute and CSAIL researchers created a machine-learning model to predict and generate protein localization, with implications for understanding and remedying disease.

The nitrogen product developed by the company, which was co-founded by Professor Chris Voigt, is being used across millions of acres of American farmland.

Xiao Wang’s studies of how and where RNA is translated could lead to the development of better RNA therapeutics and vaccines.

A new approach, which takes minutes rather than days, predicts how a specific DNA sequence will arrange itself in the cell nucleus.

In the United States and abroad, Matthew Dolan ’81 has served as a leader in immunology and virology.

Studying the pathogen R. parkeri, researchers discovered the first evidence of extensive and stable interkingdom contacts between a pathogen and a eukaryotic organelle.

A professor of genetics, toxicology, and biological engineering, Thilly pushed himself and his students to develop solutions to real-world problems.

New findings illuminate how Prochlorococcus’ nightly “cross-feeding” plays a role in regulating the ocean’s capacity to cycle and store carbon.

At a symposium of the Simons Center for the Social Brain, six speakers described a diversity of recently launched studies aimed at improving understanding of the autistic brain.

Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.

Laureates participated in various Nobel Week events, including lectures, a concert, a banquet, and the Nobel ceremony on Dec. 10.

Using high-powered lasers, this new method could help biologists study the body’s immune responses and develop new medicines.

Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.

By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.

Professor of the practice Alan Lightman’s new book digs into the wonder of striking visual phenomena in nature.

New research reveals what it takes for a protein that is best known for protecting cells against death to take on the opposite role.

The findings suggest that biochemical and physical effects of exercise could help heal nerves.

By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.

A newly characterized anti-viral defense system in bacteria aborts infection through a novel mechanism by chemically altering mRNA.

The new Tayebati Postdoctoral Fellowship Program will support leading postdocs to bring cutting-edge AI to bear on research in scientific discovery or music.

Professors Matthew Vander Heiden and Fan Wang, along with five MIT alumni, are honored for their outstanding professional achievement and commitment to service.

Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.

The scientists, who worked together as postdocs at MIT, are honored for their discovery of microRNA — a class of molecules that are critical for gene regulation.